GSK Zeasorb AF 2% Cream Recall: Incorrect Labeling Causes Misuse
GSK Consumer Healthcare recalls Zeasorb AF 2% cream due to incorrect labeling on some packages. Front labels show wrong NDC code and back labels state 'jock itch' instead of 'athlete's foot'.
Lower-risk recall
Labeling Not Elsewhere Classified: front labels have the incorrect NDC or 0145-1506-01 instead of the correct NDC of 0145-1506-05 and some back labels have the incorrect indication stating "use for the cure of most jock itch" rather than "use for the cure of most athlete's foot".
Contact the company
What happened, in plain English
GSK Consumer Healthcare is recalling Zeasorb AF 2% cream because some packages have incorrect labeling. This could lead to users applying the product for the wrong condition, potentially causing ineffective treatment or misuse. Read more at govinfonow.com/recall/42290-gsk-zeasorb-af-2-cream-recall-incorrect-labeling-causes-misuse.
Source Summary by GovInfoNow · govinfonow.com/recall/42290-gsk-zeasorb-af-2-cream-recall-incorrect-labeling-causes-misuse · Updated October 9, 2026 · FDA enforcement record: FDA #D-0142-2017
Cite this page
“GSK Zeasorb AF 2% Cream Recall: Incorrect Labeling Causes Misuse.” GovInfoNow, updated October 9, 2026. https://govinfonow.com/recall/42290-gsk-zeasorb-af-2-cream-recall-incorrect-labeling-causes-misuse. Based on FDA recall #D-0142-2017 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0142-2017%22&limit=1).
Why it’s dangerous
The product has incorrect labeling on some packages, showing the wrong NDC code and stating 'jock itch' instead of 'athlete's foot' on the back label. This could lead users to apply the cream for the wrong condition, potentially causing ineffective treatment or misuse.
Who’s affected
People who own or use Zeasorb AF 2% cream with the specific lot numbers and NDC codes listed in the recall. Those most at risk are individuals who have applied the product for jock itch when it was intended for athlete's foot.
How to tell if you have this one
Check for the NDC code 0145-1506-01 on the front label or incorrect back label stating 'jock itch' instead of 'athlete's foot'. The affected products include specific lot numbers and expiration dates listed in the recall.
- Brand
GSK Consumer Healthcare- Product
Zeasorb AF (miconazole nitrate), 2%, cures most athlete's foot, Net wt. 2.5 OZ (71 g), Manufactured for: Steifel- Category
Drug
What to do — step by step
Check Label
Verify the front label NDC code and back label indication for athlete's foot. If incorrect, stop using the product.
Where it went and when
Where it was distributed
Distributed nationwide.
FDA distribution: “Nationwide in the USA” States read from FDA’s own wording; “not listed” means the notice does not name it.
Distributed nationwide.
Recall timeline
FDA terminated this recall 2.1 years after the firm started it.
- Firm started the recall
- FDA classified it Class III
- Published in FDA’s Enforcement Report
- FDA terminated the recall
Dates from the agency record only; steps without a date are left out.
Questions people ask
Is there a risk of serious injury from this product?
No, the recall is for labeling errors that could lead to misuse, not a risk of serious injury.
Similar recalls
Latest drug recalls
Keep exploring
Where this comes from
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
- Official source: FDA Recall #D-0142-2017 (October 18, 2016) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0142-2017 to see it in context.
- Plain-language summary written by qwen3:4b on October 9, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
- GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.